Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathy.
Guerrero-Valero M, Grandi F, Cipriani S, Alberizzi V, Di Guardo R, Chicanne G, Sawade L, Bianchi F, Del Carro U, De Curtis I, Pareyson D, Parman Y, Schenone A, Haucke V, Payrastre B, Bolino A. Guerrero-Valero M, et al. Among authors: pareyson d. Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2009469118. doi: 10.1073/pnas.2009469118. Proc Natl Acad Sci U S A. 2021. PMID: 33653949 Free PMC article.
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families.
Bellone E, Mandich P, Mancardi GL, Schenone A, Uccelli A, Abbruzzese M, Sghirlanzoni A, Pareyson D, Ajmar F. Bellone E, et al. Among authors: pareyson d. J Med Genet. 1992 Jul;29(7):492-3. J Med Genet. 1992. PMID: 1640430 Free PMC article. No abstract available.
The POEMS syndrome: report of six cases.
Pareyson D, Marazzi R, Confalonieri P, Mancardi GL, Schenone A, Sghirlanzoni A. Pareyson D, et al. Ital J Neurol Sci. 1994 Oct;15(7):353-8. doi: 10.1007/BF02339932. Ital J Neurol Sci. 1994. PMID: 7698893
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].
Pareyson D, Schenone A, Fabrizi GM, Santoro L, Padua L, Quattrone A, Vita G, Gemignani F, Visioli F, Solari A; CMT-TRIAAL Group. Pareyson D, et al. Pharmacol Res. 2006 Dec;54(6):436-41. doi: 10.1016/j.phrs.2006.09.001. Epub 2006 Sep 9. Pharmacol Res. 2006. PMID: 17029975 Clinical Trial.
The use of Charcot-Marie-Tooth Neuropathy Score.
Padua L, Schenone A, Pazzaglia C, Pareyson D. Padua L, et al. Among authors: pareyson d. Eur J Phys Rehabil Med. 2009 Jun;45(2):291-2. Eur J Phys Rehabil Med. 2009. PMID: 19532113 Free article. No abstract available.
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial.
Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, Vita G, Quattrone A, Padua L, Gemignani F, Visioli F, Laurà M, Radice D, Calabrese D, Hughes RA, Solari A; CMT-TRIAAL; CMT-TRAUK groups. Pareyson D, et al. Lancet Neurol. 2011 Apr;10(4):320-8. doi: 10.1016/S1474-4422(11)70025-4. Lancet Neurol. 2011. PMID: 21393063 Free PMC article. Clinical Trial.
329 results